<DOC>
	<DOCNO>NCT00067418</DOCNO>
	<brief_summary>This study use light scatter spectroscopy ( LSS ) analyze brain tissue remove patient brain surgery determine new technology use differentiate normal cancerous cell . LSS focus light cell tissue , way light reflect back tissues provide information size cell density cell nucleus ( part cell contain gene ) . Patients 18 75 year age know suspected brain tumor patient temporal lobe epilepsy respond medication may eligible study . ( Examination tissue patient epilepsy allow comparison tumor non-tumor brain cell . ) All patient must require surgery treat condition . Participants admit Clinical Center 3 10 day physical neurological examination , blood urine test , test need prepare surgery . They undergo surgery . A small amount tissue remove surgery pathological review collect use study . Half tissue examine use LSS help determine size cell nucleus . Studies do measure many cell actively divide protein express often tumor cell compare normal cell . This information may shed light tumor cell different normal cell . Participants may contact 3 year follow health status .</brief_summary>
	<brief_title>Light Scattering Spectroscopy Determine Brain Tumors</brief_title>
	<detailed_description>Optical spectroscopy detection brain tumor tumor margin show use distinguish glioma metastatic tumor cell surround white matter . Optical spectroscopy potential provide immediate accurate diagnostic information nature quantity neoplastic cell , minimally-or non-invasive fashion . We propose use new method optical spectroscopy , polarize light-scattering spectroscopy ( LSS ) , permit discrimination malignant cancer cell normal brain cell virtue alteration cytoplasmic nuclear ratio cell . Patients suspect , prior biopsy proof , WHO grade II-IV central nervous system ( CNS ) glial tumor ( ) ; metastatic brain tumor ; patient medically-refractory temporal lobe epilepsy presume hippocampal source seizure , see Surgical Neurology Branch , NINDS , consider entry study . Tissue sample tumor normal lateral temporal neocortex resect part standard care collect surgery utilized research .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Epilepsy , Temporal Lobe</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Radiographic evidence primary glial neoplasm CNS ( WHO grade IIIV ) patient know primary neoplasm CNS ; patient know radiographic evidence resectable metastatic brain tumor ( ) ; patient temporal lobe epilepsy ( TLE ) resective surgery , include lateral termporal neocortex , indicate . 2 . Informed consent patient age 18 old . 3 . No racial ethnic group gender exclude . 4 . Pregnant woman require brain surgery may participate study . EXCLUSION CRITERIA : 1 . Inability provide inform consent prior surgery . 2 . Medical condition correct prior surgery would standard contraindication neurosurgery .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Glioma</keyword>
	<keyword>Brain Tumor</keyword>
	<keyword>Spectroscopy</keyword>
</DOC>